Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

Antiprotozoal Agents

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...

Drugs for Treatment of Diarrhea-Predominant IBS

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In silico identification and deorphanisation of an allatostatin C GPCR system in the cephalopod Octopus vulgaris reveal two receptors with distinct potency.

Neuropeptides·2026

Same author

An investigation into the use of Caenorhabditis elegans as a model organism for nerve agent exposure research.

Neurotoxicology·2026

Same author

Identification of molecular nociceptors in Octopus vulgaris through functional characterisation in Caenorhabditis elegans.

Biology open·2025

Same author

Urinary proteomic profiling to identify early biomarkers of non-diabetic chronic kidney disease.

Clinical kidney journal·2025

Same author

Optimizing a <i>C. elegans</i> whole organism screen biased for chemicals that target the nematode clade specific receptor EAT-2.

microPublication biology·2025

Same author

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Intensive care medicine·2025

Search research articles

Related Experiment Video

Updated: Jul 10, 2026

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Anthelmintic drugs.

Lindy Holden-Dye¹, Robert J Walker

¹School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton SO16 7PX, UK. lmhd@soton.ac.uk

Wormbook : the Online Review of C. Elegans Biology

|November 9, 2007

Summary

The nematode Caenorhabditis elegans (C. elegans) serves as a valuable model parasite for studying anthelmintic drug mechanisms. Its sensitivity to common drugs aids in understanding drug actions and cell signaling pathways.

Area of Science:

Parasitology
Molecular Biology
Pharmacology

Background:

The nematode Caenorhabditis elegans (C. elegans) exhibits sensitivity to numerous anthelmintic drugs used in human and veterinary medicine.
This sensitivity enables the application of molecular genetic techniques for elucidating drug mechanisms of action.

Purpose of the Study:

To review the utility of C. elegans as a model organism in parasitology.
To outline the mechanisms of action for major classes of anthelmintic drugs.
To highlight valuable methodologies employing C. elegans in anthelmintic research.

Main Methods:

Utilizing C. elegans in forward genetic screens to identify genes affecting drug susceptibility.
Mapping and characterizing genes involved in altered responses to anthelmintics.

More Related Videos

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

Helminth Collection and Identification from Wildlife

Helminth Collection and Identification from Wildlife

Published on: December 14, 2013

Related Experiment Videos

Last Updated: Jul 10, 2026

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Evaluation of Antioxidant and Anthelmintic Properties of Tithonia diversifolia Extracts Against Gastrointestinal Nematode Eggs Using In Vitro Assays

Published on: August 1, 2025

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Determining Soil-transmitted Helminth Infection Status and Physical Fitness of School-aged Children

Published on: August 22, 2012

Helminth Collection and Identification from Wildlife

Helminth Collection and Identification from Wildlife

Published on: December 14, 2013

Employing anthelmintics as pharmacological tools to study cell signaling pathways.

Main Results:

Anthelmintic drugs have been instrumental in dissecting fundamental cell signaling pathways in C. elegans.
Genetic screens using C. elegans have successfully identified key genes related to drug action.
While direct anthelmintic discovery has been less fruitful, C. elegans remains valuable for drug mechanism studies.

Conclusions:

C. elegans is a powerful model system for understanding anthelmintic drug action and cell signaling.
Molecular genetic approaches in C. elegans provide significant insights for the field of parasitology.
Further exploration of C. elegans in drug discovery programs holds potential for future advancements.